FOLLOW US
For Professionals » Research Updates » Diabetes complications

Diabetes complications Research Updates

For Medical Professionals

Statins Remains Therapy of Choice for Most People at Risk for CVD
Fluctuations in Albumin May Forecast Progression of Kidney Disease
Proton Pump Inhibition: Pros and Cons of Extended Use in Type 2 Diabetes
Glucose Management Indicator Replaces eA1c in Patients with CGM Sensors
Emerging Medical Management of Type 2 Diabetes in Older Adults
Wholistic Approach to Care Leads Changes in 2019 Diabetes Guidelines
Cardiovascular Outcomes Remain Primary Focus of Drug Trials
New Treatment Reduces Adverse Effects of Cardiomyopathy by One-Third
Predicting Cardiovascular Disease Events in Type 2 Diabetes
Reversing Diabetes By Awakening Beta Cells—Nearly There
Advancing Diabetes Care: Longer Use FreeStyle Sensor, Nasal Glucagon
Novel Diabetes Devices on the Horizon to Improve Glucose Management
Bariatric Surgery Remains Missed Opportunity for Medical Care
Fibroblast Growth Factor-23 Explored As Biomarker for Coronary Heart Disease
For Type 2 Diabetes, Less Intensive HbA1c Goals Promise Less Harm
First In-Office Screening for Diabetic Retinopathy Cleared by FDA
Cholesterol Guidelines: Better to Individualize High Cholesterol Treatment
Immediate-Acting Mealtime Insulin Analog — Fiasp — Received FDA Approval
ADA Issues Position Statement to Manage Diabetes and Hypertension
Treating Hepatitis C May Improve Glucose Control in People with Diabetes
close X
SHOW MAIN MENU
SHOW SUB MENU